Table 1.
Variables | HR | 95% CI | p-Value |
---|---|---|---|
Univariate Analysis | |||
Age | 1.047 | 0.997–1.099 | NS |
Gender | 0.743 | 0.33–1.67 | NS |
∆ Body fat percentage/duration (months) | 0.418 | 0.188–0.929 | 0.0323 * |
Availability of oral food intake | 0.228 | 0.053–0.975 | 0.0461 * |
∆ Phase angle/duration (months) | 0.429 | 0.194–0.952 | 0.0374 * |
∆ ECW/TBW/duration (months) | 2.871 | 1.261–6.535 | 0.012 * |
∆ Skeletal muscle index/duration (months) | 1.31 | 0.601–2.855 | NS |
∆ Muscle mass/duration (months) | 1.763 | 0.808–3.846 | NS |
∆ Fat-free mass/duration (months) | 1.448 | 0.667–3.146 | NS |
∆ Skeletal muscle mass/duration (months) | 2.042 | 0.925–4.509 | NS |
∆ Basal metabolism rate/duration (months) | 1.679 | 0.771–3.659 | NS |
∆ Weight/duration (months) | 1.635 | 0.686–3.896 | NS |
∆ BMI/duration (months) | 1.635 | 0.686–3.896 | NS |
Presence of tracheostomy | 1.133 | 0.464–2.764 | NS |
Multivariate Analysis | |||
∆ Body fat percentage/duration (months) | 0.374 | 0.158–0.882 | 0.0247 * |
Availability of oral food intake | 0.167 | 0.037–0.755 | 0.02 * |
∆ Phase angle/duration (months) | 1.215 | 0.177–8.344 | NS |
∆ ECW/TBW/duration (months) | 3.03 | 0.429–21.384 | NS |
HR—hazard ratio; CI—confidence interval. HRs were adjusted for the listed variables. * p < 0.05.